I was certain this was going to phase 3. The highlight for me in this announcement is the endpoint is over 12 weeks. Even though covid will delay commencement until next year, we should see commercialisation in 2021$$$$$. It also sounds like they have found a way to improve the formula and will trial this with Rosacea.
Ann: BTX 1503 End of Phase 2 Milestone with FDA, page-70
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.005(1.30%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.0¢ | $492.0K | 1.273M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 667183 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 201969 | 12 |
View Market Depth
| Last trade - 10.53am 17/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |